233 related articles for article (PubMed ID: 10202035)
1. CD26/dipeptidyl-peptidase IV down-regulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin by affecting its interaction with CC chemokine receptor 3.
Struyf S; Proost P; Schols D; De Clercq E; Opdenakker G; Lenaerts JP; Detheux M; Parmentier M; De Meester I; Scharpé S; Van Damme J
J Immunol; 1999 Apr; 162(8):4903-9. PubMed ID: 10202035
[TBL] [Abstract][Full Text] [Related]
2. Cloning and characterization of the guinea pig eosinophil eotaxin receptor, C-C chemokine receptor-3: blockade using a monoclonal antibody in vivo.
Sabroe I; Conroy DM; Gerard NP; Li Y; Collins PD; Post TW; Jose PJ; Williams TJ; Gerard CJ; Ponath PD
J Immunol; 1998 Dec; 161(11):6139-47. PubMed ID: 9834099
[TBL] [Abstract][Full Text] [Related]
3. Identification of a mouse eosinophil receptor for the CC chemokine eotaxin.
Gao JL; Sen AI; Kitaura M; Yoshie O; Rothenberg ME; Murphy PM; Luster AD
Biochem Biophys Res Commun; 1996 Jun; 223(3):679-84. PubMed ID: 8687456
[TBL] [Abstract][Full Text] [Related]
4. Enhanced anti-HIV-1 activity and altered chemotactic potency of NH2-terminally processed macrophage-derived chemokine (MDC) imply an additional MDC receptor.
Struyf S; Proost P; Sozzani S; Mantovani A; Wuyts A; De Clercq E; Schols D; Van Damme J
J Immunol; 1998 Sep; 161(6):2672-5. PubMed ID: 9743322
[TBL] [Abstract][Full Text] [Related]
5. Eotaxin activates T cells to chemotaxis and adhesion only if induced to express CCR3 by IL-2 together with IL-4.
Jinquan T; Quan S; Feili G; Larsen CG; Thestrup-Pedersen K
J Immunol; 1999 Apr; 162(7):4285-92. PubMed ID: 10201960
[TBL] [Abstract][Full Text] [Related]
6. Eotaxin potentiates antigen-dependent basophil IL-4 production.
Devouassoux G; Metcalfe DD; Prussin C
J Immunol; 1999 Sep; 163(5):2877-82. PubMed ID: 10453034
[TBL] [Abstract][Full Text] [Related]
7. The allergy-associated chemokine receptors CCR3 and CCR5 can be inactivated by the modified chemokine NNY-CCL11.
Manns J; Rieder S; Escher S; Eilers B; Forssmann WG; Elsner J; Forssmann U
Allergy; 2007 Jan; 62(1):17-24. PubMed ID: 17156337
[TBL] [Abstract][Full Text] [Related]
8. Dipeptidyl peptidase IV (CD26) on T cells cleaves the CXC chemokine CXCL11 (I-TAC) and abolishes the stimulating but not the desensitizing potential of the chemokine.
Ludwig A; Schiemann F; Mentlein R; Lindner B; Brandt E
J Leukoc Biol; 2002 Jul; 72(1):183-91. PubMed ID: 12101279
[TBL] [Abstract][Full Text] [Related]
9. Human eotaxin represents a potent activator of the respiratory burst of human eosinophils.
Elsner J; Höchstetter R; Kimmig D; Kapp A
Eur J Immunol; 1996 Aug; 26(8):1919-25. PubMed ID: 8765040
[TBL] [Abstract][Full Text] [Related]
10. The carboxyl terminus of the chemokine receptor CCR3 contains distinct domains which regulate chemotactic signaling and receptor down-regulation in a ligand-dependent manner.
Sabroe I; Jorritsma A; Stubbs VE; Xanthou G; Jopling LA; Ponath PD; Williams TJ; Murphy PM; Pease JE
Eur J Immunol; 2005 Apr; 35(4):1301-10. PubMed ID: 15739168
[TBL] [Abstract][Full Text] [Related]
11. A novel human CC chemokine, eotaxin-3, which is expressed in IL-4-stimulated vascular endothelial cells, exhibits potent activity toward eosinophils.
Shinkai A; Yoshisue H; Koike M; Shoji E; Nakagawa S; Saito A; Takeda T; Imabeppu S; Kato Y; Hanai N; Anazawa H; Kuga T; Nishi T
J Immunol; 1999 Aug; 163(3):1602-10. PubMed ID: 10415065
[TBL] [Abstract][Full Text] [Related]
12. Novel co-operation between eotaxin and substance-P in inducing eosinophil-derived neurotoxin release.
El-Shazly A; Ishikawa T
Mediators Inflamm; 1999; 8(3):177-9. PubMed ID: 10704057
[TBL] [Abstract][Full Text] [Related]
13. Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes.
Forssmann U; Uguccioni M; Loetscher P; Dahinden CA; Langen H; Thelen M; Baggiolini M
J Exp Med; 1997 Jun; 185(12):2171-6. PubMed ID: 9182688
[TBL] [Abstract][Full Text] [Related]
14. Eotaxin is a potent chemotaxin for human basophils.
Yamada H; Hirai K; Miyamasu M; Iikura M; Misaki Y; Shoji S; Takaishi T; Kasahara T; Morita Y; Ito K
Biochem Biophys Res Commun; 1997 Feb; 231(2):365-8. PubMed ID: 9070280
[TBL] [Abstract][Full Text] [Related]
15. Functional comparison of two human monocyte chemotactic protein-2 isoforms, role of the amino-terminal pyroglutamic acid and processing by CD26/dipeptidyl peptidase IV.
Van Coillie E; Proost P; Van Aelst I; Struyf S; Polfliet M; De Meester I; Harvey DJ; Van Damme J; Opdenakker G
Biochemistry; 1998 Sep; 37(36):12672-80. PubMed ID: 9730840
[TBL] [Abstract][Full Text] [Related]
16. Identification of potent, selective non-peptide CC chemokine receptor-3 antagonist that inhibits eotaxin-, eotaxin-2-, and monocyte chemotactic protein-4-induced eosinophil migration.
White JR; Lee JM; Dede K; Imburgia CS; Jurewicz AJ; Chan G; Fornwald JA; Dhanak D; Christmann LT; Darcy MG; Widdowson KL; Foley JJ; Schmidt DB; Sarau HM
J Biol Chem; 2000 Nov; 275(47):36626-31. PubMed ID: 10969084
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticosteroids inhibit mRNA expression for eotaxin, eotaxin-2, and monocyte-chemotactic protein-4 in human airway inflammation with eosinophilia.
Jahnsen FL; Haye R; Gran E; Brandtzaeg P; Johansen FE
J Immunol; 1999 Aug; 163(3):1545-51. PubMed ID: 10415058
[TBL] [Abstract][Full Text] [Related]
18. A novel, selective, and orally available antagonist for CC chemokine receptor 3.
Morokata T; Suzuki K; Masunaga Y; Taguchi K; Morihira K; Sato I; Fujii M; Takizawa S; Torii Y; Yamamoto N; Kaneko M; Yamada T; Takahashi K; Shimizu Y
J Pharmacol Exp Ther; 2006 Apr; 317(1):244-50. PubMed ID: 16339911
[TBL] [Abstract][Full Text] [Related]
19. Characterization of chemokine CCR3 agonist-mediated eosinophil recruitment in the Brown-Norway rat.
Kudlacz EM; Whitney CA; Andresen CJ; Umland JP; Cheng JB
Br J Pharmacol; 1999 Oct; 128(3):788-94. PubMed ID: 10516663
[TBL] [Abstract][Full Text] [Related]
20. Cleavage by CD26/dipeptidyl peptidase IV converts the chemokine LD78beta into a most efficient monocyte attractant and CCR1 agonist.
Proost P; Menten P; Struyf S; Schutyser E; De Meester I; Van Damme J
Blood; 2000 Sep; 96(5):1674-80. PubMed ID: 10961862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
